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Abstract
Background: Only few case reports of mucinous cystic pancreatic neoplasm containing an undifferentiated
carcinoma with osteoclast-like giant cells have been described in the literature. In the majority of cases this unusual
association of tumors seems related to a favorable outcome. We present the second case of an indeterminate
mucin-producting cystic neoplasm containing an area of carcinoma with osteoclast-like giant cells. The specific
features of the two histotypes and the rapid course of the disease make our clinical case remarkable.
Case presentation: A 68 year old female came to our attention for a pancreatic macrocystic mass detected with
ultrasonography. Her past medical history was silent. The patient reported upper abdominal discomfort for two
months; nausea, vomiting or weight loss were not reported. Physical examination revealed a palpable mass in the
epigastrium; scleral icterus was absent. Cross-sectional imaging showed a complex mass of the neck and body of
the pancreas, characterized by multiple large cystic spaces separated by thick septa and an area of solid tissue
located in the caudal portion of the lesion. The patient underwent total pancreatectomy with splenectomy.
Pathological examination revealed a mucinous cystic neoplasm with a component of an undifferentiated carcinoma
with osteoclast-like giant cells. Because of the absence of ovarian-type stroma, the lesion was classified as an
indeterminate mucin-producing cystic neoplasm of the pancreas. The immunohistochemical studies evidenced no
reactivity of osteclast-like giant cells to epithelial markers but showed a positive reactivity to histiocytic markers.
Numerous pleomorphic giant cells with an immunohistochemical sarcomatoid profile were present in the
undifferentiated carcinoma with osteoclast-like giant cells. A rapid tumor progression was observed: liver metastases
were detected after 4 months. The patient received adjuvant chemotherapy (Gemcitabine) but expired 10 months
after surgery.
Conclusion: Our case confirms that the presence of a solid area in a cystic pancreatic tumor at cross-sectional
imaging should raise a suspicion of malignant transformation. The lack of ovarian-type stroma in a pancreatic
mucinous cystic neoplasm and the presence of pleomorphic giant cells in an undifferentiated carcinoma with
osteoclast-like giant cells could be a marker of a poor prognosis.
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Background
The World Health Organization (WHO) classifies pan-
creatic mucin-producing cystic tumors into two different
pathological entities: mucinous cystic neoplasm (MCN)
and intraductal papillary mucinous neoplasm (IPMN)
[1]. MCNs are thick-walled macrocystic tumors charac-
terized by the absence of communication with ductal
system. The distinctive histological feature of an MCN is
a columnar mucin-producing epithelium supported by
an ovarian-type stroma; this neoplasm occurs typically
in premenopausal women [1–3]. IPMNs are intraductal
tumors characterized by epithelial papillary proliferation
and mucin hypersecretion causing a typical cystic dilata-
tion of the pancreatic ductal system. IPMNs occur fre-
quently in the head of the gland and are characterized
by the communication between the tumor and the pan-
creatic ducts [1, 3]. IPMN has an equal gender distribu-
tion and occurs frequently in the seventh decade of life
[1]. On the basis of epithelial atypia and invasiveness,
cystic neoplasms are classified as adenoma, non-invasive
carcinoma and invasive carcinoma [1, 3].
The undifferentiated carcinoma is a rare and aggressive
form of pancreatic neoplasm. The WHO classification
describes two distinct histological types: osteoclast-like
giant cell carcinoma (OGCC) and pleomorphic giant cell
carcinoma (PGCC) [1]. PGCC shows a sarcomatoid
growth pattern, characterized by the presence of pleo-
morphic mononucleated and multinucleated bizarre
giant cells [1, 4]. OGCC is composed of spindle-shaped or
ovoidal mononuclear cells and scattered giant cells with
multiple small regular nuclei [1, 4].
In 1981, Posen described for the first time the associ-
ation of a giant cell tumor of the osteoclastic type with a
mucous secreting cystic pancreatic neoplasm and since
then only 12 cases have been reported [5, 6]. In a recent
review Wada et al. analyzing all the cases in the litera-
ture, reported a favourable prognosis for this particular
tumor association [6]. We present the second case in the
literature of a patient with an indeterminate mucin-
producting cystic neoplasm containing a single area of
undifferentiated carcinoma with osteoclast- like giant
cells, characterized by a rapid disease progression.
Case presentation
Clincal history and treatment
A 68 year old caucasian female with a pancreatic cystic
neoplasm diagnosed on ultrasonography (US) presented
at our Institute in December 2013. Her past medical his-
tory was silent. No abuse of ethanol or smoking was re-
ported. The patient reported upper abdominal discomfort
for 2 months; nausea, vomiting or weight loss were not re-
ferred. The physical examination revealed a palpable mass
in the epigastrium; scleral icterus was absent. No other
clinical abnormalities were detected.
The US showed a 5 × 6 cm pancreatic macrocystic le-
sion localized in the body of the gland. Laboratory tests
showed that blood cell counts and C-reactive protein were
normal. Levels of serum glucose, creatinine, albumin, ami-
notransferase, gamma-glutamyl transferase, alkaline phos-
phatase and lipase were all within normal limits. The
serum levels of the following tumor markers were ele-
vated: carcino-embryonic antigen (CEA) was 196 ng/ml
(normal range <5 ng/ml) and carbohydrate antigen 19-9
(CA 19-9) was 66 U/ml (normal range <33 U/ml).
The patient underwent a triphasic multidetector com-
puted tomography (CT) scan and a T1, T2-weighted and
DWI contrast enhanced magnetic resonance imaging
(MRI) with intravenous Gadolinium administration.
The CT scan showed a large complex cystic and solid
mass measuring 5 × 3 × 6 cm involving the neck and the
body of the pancreas (Fig. 1a). The tumor had a predom-
inant central component characterized by multiple large
cystic spaces (up to 3 cm in diameter) separated by thick
septa. A 2 cm area of low attenuation solid tissue was lo-
cated between cyst walls in the caudal portion of the le-
sion. The main pancreatic duct was enlarged in its
entirity (diameter 12 mm) with a more marked dilatation
in the body and tail region. Irregular calcifications were
evident in the peripheral portion of the tumor. There
was compression of superior mesenteric vein by the
mass with a minimal infiltration of the splenic vein. The
CT scan of the chest and abdomen did not show any
lymphadenopathy, hepatic and pulmonary metastasis.
MRI confirmed the complex pancreatic lesion featured
by a large cystic portion with inner irregular septa and a
peripheral solid area measuring 2 cm in the lower portion
of the tumor (Fig. 1b). Cholangiopancreatographic images
did not demonstrate a communication between the en-
larged main pancreatic duct and the cystic mass; ectatic
branch ducts were present in the body and tail region.
At laparotomy a large cystic mass involving the body
and the neck of pancreas was confirmed. Further explor-
ation showed an infiltration of the head of the gland but
ruled out neoplastic spreading to adjacent organs and
lymph nodes; the splenic vein was infiltrated by the mass
at superior mesenteric veinous junction. Patient under-
went total pancreatectomy with splenectomy and lymph
node dissection. A US performed on 7th post-operative
day ruled out any intra-abdominal fluid collection. Pa-
tient developed post-pancreaectomy diabetes which was
difficult to control by insulin therapy. The patient was
discharged 14 days after the operation.
Histopathological findings
Macroscopically the pancreas was involved by a 6 cm well-
circumscribed round mass localized in the neck and the
body with infiltration of the head; stomach, duodenum,
common bile duct and spleen were not infiltrated.
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Externally the tumor presented a smooth reddish surface
and the pancreatic parenchyma not involved by the lesion
appeared fibrotic. On cut-section the lesion showed multi-
locular macrocystic spaces separated by fibrous septa and
filled by a clear viscous mucoid fluid. The main pancreatic
duct was ectatic but it was not possible to recognize a
communication with the cystic lesion. A 2 cm single yellow
solid area was located in the caudal portion of the mass.
Microscopically the tumor was principally composed of a
cystic mucinous part characterized by a columnar mucin-
ous epithelium with atypical nuclei, copious mitoses and
stromal invasion. It was not possible to find an ovarian-like
stroma (Fig. 2a). In the caudal part of the neoplasm there
was a solid area containing mononuclear spindle cells, asso-
ciated with pleomorphic giant cells (PGCs) and scattered
multinucleated osteoclast-like giant cells (OGCs) (Fig. 2b).
The surgical margins were negative for neoplastic infil-
tration. No lymph node metastases were shown. There
was no evidence of perineural or vascular infiltration.
The mononuclear spindle cells and pleomorphic giant
cells were immunoreactive for epithelial markers includ-
ing CK8/18 and CK19, and for vimentin and expressed a
weak immunoreactivity for CD68 and a focal immunoreac-
tivity for actin and CD10. The proliferative index (Ki-67) of
the mononuclear spindle cells and pleomorphic giant cells
was high (approximately 30 %) (Fig. 3a). Multinucleated
Fig. 1 a Contrast enhanced CT scan demonstrates a complex pancreatic macrocystic mass involving the neck and the body of the pancreas with
a peripheral solid portion. b Axial T2-weighted MRI shows the high-intensity central cystic portion of the mass with inner irregular septa and the
peripheral less intense solid tissue determining main duct dilatation
Fig. 2 a Microscopically the tumor is characterized by a predominant cystic lesion composed of a columnar mucinous epithelium with atypical nuclei,
numerous mitoses and stromal invasion. An ovarian-type stroma is absent (hematoxylin/eosin staining, 20x). b The solid area contains mononuclear
spindle-shaped cells, pleomorphic giant cells and scattered multinucleated osteoclast-like giant cells (hematoxylin/eosin staining, 20x)
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osteoclast-like giant cells intensely expressed histio-
cytic marker (CD68) and vimentin but they were
negative for epithelial markers (CK8/18 and CK19)
and actin. In these cells Ki-67 immunoreaction was
negative (Fig. 3b).
The histopathological findings supported the diagnosis
of indeterminate mucin-producing cystic neoplasm with
a component of osteoclast-like giant cell carcinoma.
Follow-up
Two months after surgery serum CEA and CA 19-9 de-
creased to 83 ng/ml and 31 U/ml, respectively. Neverthe-
less after 4 months serum CEA increased to 144 ng/ml
and hepatic metastases were founded at follow-up CT
scan. Gemcitabine single agent chemotherapy was started
(1,00 mg/m2 weekly × 7, then weekly × 3 every 4 weeks).
CT scan performed 8 months after surgery showed the
progression of liver metastases and appearance of lung
metastases. The patient expired 10 months after surgery.
Discussion
International Consensus Guidelines have established
how to diagnose and manage pancreatic cystic tumors
[7]. Although their clinical, radiological and pathological
features have been defined, in some cases the differential
diagnosis between mucinous forms is difficult [8].
In our case the assessment of a correct preoperative
diagnosis was difficult due to the clinical and radio-
logical findings. Patient’s age and main duct dilatation
were elements in favor of IPMN, while female gender
and the involvement of the body of the gland leaned to-
wards MCN. However the diagnosis of IPMN was ex-
cluded as there was no communication between the
cystic mass and the main pancreatic duct.
Tumor size, peripheral calcifications, irregular septa,
and the presence of an intramural nodule pointed to-
wards malignant transformation and led to surgical re-
section. Indeed all these radiological findings are very
frequently associated with malignant histology [9].
On the basis of microscopic criteria (nuclear atypia,
number of mitoses, and invasion into the stroma), the
lesion should be categorized as a mucinous cystoadeno-
carcinoma. Nevertheless the absence of ovarian-type
stroma made us to classify it as an indeterminate mucin-
producing cystic neoplasm of the pancreas [7]. In the lit-
erature the lack of ovarian-type stroma is more frequent
in postmenopausal women and MCNs that do no ex-
press ovarian-type stroma have a worse prognosis com-
pared to those which have ovarian-type stroma [2, 10].
OGCC is rare pancreatic neoplasm: a US popula-
tion study based on Surveillance, Epidemiology and
End Result (SERR) database evidenced that its inci-
dence is 11 % of all undifferentiated carcinomas of
the pancreas [11].
In the past decades the histogenesis of OGCC was de-
bated, but the more recent immunohistochemical stud-
ies demonstrate that OGCs present no reactivity to
epithelial markers and show a positive reactivity to his-
tiocytic marker CD68; by contrast, spindle-shaped
mononuclear cells express epithelial markers [12, 13].
The immunoreactivity for Ki-67 reveals a low prolifera-
tive activity of OGCs and a high proliferative activity for
mononuclear cells [13]. These data, as our findings, con-
firm the hypothesis that spindle-shaped mononuclear
cells are neoplastic elements, while OGCs are not neo-
plastic and may have a histiocytic lineage [12, 13].
In our case numerous PGCs were detected in the solid
area of the neoplasm. These cells are frequently character-
ized by immunoreactivity for epithelial markers like
Fig. 3 a Mononuclear spindle-shaped cells and pleomorphic giant cells (arrow) are immunoreactive for epithelial markers (CK8/18), while multinucleated
osteoclast-like giant cells are negative (40x). b Mononuclear spindle-shaped cells and pleomorphic giant cells stain weakly for histiocytic marker CD68; in
contrast, multinucleated osteoclast-like giant cells show an intense immunoreactivity for CD68 (arrow) (40x)
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cytokeratins and CEA and by a high proliferative index; in
some cases, PGCs express mesenchymal markers like
vimentin [14]. These data support the hypothesis that
PGCs are undifferentiated neoplastic cells derived from
epithelial elements with a sarcomatoid profile. These histo-
logical changes are typical of the epithelial-mesenchimal
transition which is a marker of tumor de-differentiation
and invasiveness [15].
The simultaneous presence of PGCs and OGCs within
the same tumor indicates a possible overlap between the
two histological types: some authors propose to classify
the mixed giant cell carcinoma as a different histopatho-
logical entity containing both osteoclastic and pleo-
morphic giant cells in significant proportion [4, 14, 16].
Incongruous data is there in the literature about OGCC
prognosis. Early reports based on single case suggested
that it might have a better outcome than ordinary ductal
carcinoma [17]. However in a series of nine cases all pa-
tients but one died within 1 year from diagnosis [12]. In a
retrospective analysis of 15 patients with anaplastic carcin-
oma of the pancreas, all long-term survivors presented a
neoplasm containing OGCs and the median survival was
significantly better in this histological type [18]. In two
small series, OGCCs with a high proportion of PGCs were
associated with a shorter survival [13, 19] and in an overall
analysis of the few reported cases, the presence of a cell
population expressing epithelial markers seemed to pre-
dict a worse prognosis [20].
Ours is the second case described in the english lit-
erature of an indeterminate mucin-producting cystic
neoplasm containing an area of undifferentiated car-
cinoma with osteoclast-like giant cells. In a review
that analyzed all cases of MCN associated with
OGCC, 10 of 12 patients were alive at follow-up [6].
By contrast our report was remarkable for the rapid
progression of the tumor. It is interesting to note that
both cystic and solid components of the neoplasm
presented histological features of malignancy. Only
further studies based on large series with longer
follow-up will clarify if the absence of ovarian-type
stroma and the presence of PGCs could be related
with the outcome of these tumors.
Conclusions
There are only few case reports in literature of an MCN
with a component of OGCC. Due to limited data it is
difficult to establish accurately radiological presentation
and clinical outcome of these patients. Our case con-
firms that the presence of solid area in a cystic tumor at
cross-sectional imaging should raise a suspicion of ma-
lignant transformation. In conclusion, the peculiar histo-
logical features of the two neoplasms and the rapid
course of the disease make our case remarkable.
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